Canada markets close in 5 hours 40 minutes

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.9050+0.1050 (+5.83%)
As of 10:20AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 490.24M
Enterprise Value 859.69M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.34
Price/Book (mrq)0.76
Enterprise Value/Revenue 4.29
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 2.04
52-Week Change 3-86.00%
S&P500 52-Week Change 321.83%
52 Week High 313.7000
52 Week Low 31.1600
50-Day Moving Average 31.7296
200-Day Moving Average 35.0349

Share Statistics

Avg Vol (3 month) 310M
Avg Vol (10 day) 312.96M
Shares Outstanding 5272.36M
Implied Shares Outstanding 6272.36M
Float 8270.9M
% Held by Insiders 11.89%
% Held by Institutions 194.97%
Shares Short (Jun 28, 2024) 456.47M
Short Ratio (Jun 28, 2024) 47.3
Short % of Float (Jun 28, 2024) 423.88%
Short % of Shares Outstanding (Jun 28, 2024) 420.73%
Shares Short (prior month May 31, 2024) 454.25M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024


Profit Margin -148.13%
Operating Margin (ttm)-209.82%

Management Effectiveness

Return on Assets (ttm)-10.84%
Return on Equity (ttm)-44.28%

Income Statement

Revenue (ttm)200.43M
Revenue Per Share (ttm)0.77
Quarterly Revenue Growth (yoy)-0.20%
Gross Profit (ttm)N/A
EBITDA -282.54M
Net Income Avi to Common (ttm)-296.9M
Diluted EPS (ttm)-1.1400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)561.91M
Total Cash Per Share (mrq)2.06
Total Debt (mrq)931.37M
Total Debt/Equity (mrq)143.50%
Current Ratio (mrq)9.28
Book Value Per Share (mrq)2.38

Cash Flow Statement

Operating Cash Flow (ttm)-240.16M
Levered Free Cash Flow (ttm)-304.23M